Burkina Faso and Mali’s fabulous flora: new plant life record released 
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Instagram Outage Disrupts Thousands of U.S. Users 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
LA fires: Long-term exposure to wildfire smoke is poorly understood − and a growing risk 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
An unexpected anomaly was found in the Pacific Ocean – and it could be a global time marker 
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 
AB InBev would sell at "very low" prices or even give away the spent grains left over from the brewing process that could be converted to protein to help address increasing global food and sustainability challenges,
After three years working with AB InBev, the startup EverGrain has developed ingredients used in protein shakes and bars, bread, and barley milk.
With a new factory slated to open in St. Louis in March, AB InBev says expects EverGrain to haul in $20 million next year.
ZX Ventures is also hoping to leverage AB InBev's fermentation knowledge to scale up the production of alternative proteins through its company BioBrew.
Bernardo Novick, the global head of the AB InBev incubator ZX Ventures, emphasized that no one in the world possesses as much scaled fermentation knowledge as ABI. He added that the application of biotechnology to food and beverage is expected to be a massive opportunity in the next 10 to 20 years.
He noted that the market for alternative fermented protein alone is estimated to reach $22 billion by 2035.
But Novick admitted that BioBrew is still in exploratory spaces as to the kinds of products it could produce.
According to AB InBev CEO Michel Doukeris, the company pledged to combine its brewing infrastructure and expertise with biotech advancements to help address increasing global food and sustainability challenges.
He added that the company can leverage its core brewing and fermentation capabilities in new and exciting ways.
AB InBev expects $57 billion in sales for 2022.
